Lindsey Column Highlights AIs RealityBending Impact Truth Stranger Than Fiction Travel Insurance for Foreign Trips Whats Covered and Whats Excluded Speculation Surfaces Could SpaceX Intel Merge in a 1 Trillion Deal Federal Reserve May Face Limited Justification for Interest Rate Cuts as Jobs Report Highlights Persistent Cost of Living Pressures Vickers Report Highlights Insider Trading Activity on May 27 2026 Memorial Day Market Closures What Investors Need to Know VICR Q1 2026 Earnings EPS Surges Past Estimates with 1983 Surprise ESLA Q1 2026 Earnings WiderThanExpected Loss and No Revenue Highlight DevelopmentStage Challenges Corvex Inc MOVE Q1 2026 Earnings EPS Beat Boosts Shares as Loss Narrows SYBT Q1 2026 Earnings Small EPS Beat Meets Modest Market Reaction Eagle Point Credit Company Inc ECC Q4 2025 Earnings EPS Surpasses Estimates Stock Gains 21 VRSN Q1 2026 Earnings Earnings Beat Expectations Driven by Domain Base Stability Genenta Science GNTA Dips 169 Nearing Key Support at 055 iHeartMedia Stock Plunges 96 as Media Sector Headwinds Intensify IHRT Li Bang International LBGJ Holds Near Support with Minimal Price Movement Citizens Financial Group CFG Edges Higher as Bank Stocks Gain Traction Ambarella AMBA Rallies 35 as Volume Surges Above Support ELVA Q1 2026 Earnings EPS Surprise of 307 Drives Optimism USPH Q1 2026 Earnings EPS Misses Estimates by 1725 but Stock Gains 332 MHH Q1 2026 Earnings EPS Miss Disappoints Despite Positive Stock Movement INDV Q1 2026 Earnings EPS Beat Drives 437 Surprise as Stock Declines SAIC Q1 2026 Earnings Strong EPS Surprise Drives Stock Higher SYPR Q3 2025 Earnings Returns to Profitability with EPS of 002 as Shares Rally Bitcoin Slips to 74500 Set for Weekly Decline Amid Geopolitical Jitters UAN Q1 2026 Earnings Strong EPS of 472 Driven by Favorable Nitrogen Market Conditions Expro Group Holdings XPRO Edges Higher Amid Modest Gains Key Levels in Focus LOPE Q1 2026 Earnings Earnings Beat Estimates Amid Enrollment Stability MGRX Q3 2025 Earnings Narrowing Losses as Strategic Pivot Gains Momentum SYRE Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline FOLD Q4 2025 Earnings EPS Falls Short of Estimates Stock Unchanged Verrica Pharmaceuticals VRCA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Sees Modest Stock Gain TM Q1 2026 Earnings EPS Beat Driven by Cost Controls and Robust Global Sales UHAL Q1 2026 Earnings Significant EPS Miss Despite Modest Stock Gain